🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🫀In observance of #AmericanHeartMonth, we're sharing this #ASBMBToday article by Marissa Locke Rottinghaus: bit.ly/4hM1MAE. Read on to learn about a study, published in Journal of Biological Chemistry, using mice that revealed a way to turn back the clock after a heart attack. bit.ly/4hM1MAE

While enjoying the cutting-edge science at #ASBMB25, check out Chicago’s diverse culture, iconic landmarks delicious food and more recommended by the ASBMB Student Chapter members at Loyola University Chicago! ow.ly/fsIk50Vixqf

With the National Institutes of Health and other institutions canceling summer programs, many students are left scrambling for alternatives. If your program has been canceled or delayed, consider applying for other opportunities or taking a course. ow.ly/W8vm50VixrO

Kayunta Johnson-Winters, UTA Chemistry & Biochemistry associate professor, has been named a 2025 ASBMB Fellow in recognition of her contributions to biochemistry and molecular biology and her efforts to support junior faculty, women in science and student mentorship. uta.edu/academics/scho…

Congratulations to ASBMB member Claus Schneider and colleagues on this recent publication! #ASBMBmemberMonday

📣Congratulations 🎉 to Prof. Johnson-Winters @KayuntaJ on being named a 🥇2025 ASBMB Fellow🏆! This is a remarkable achievement that recognizes her scientific 🔬🥼🧬 and mentorship 📝📚 contributions to biochemistry 🧬and molecular biology🦠‼️ #MaverickScience x UTA Science

asbmb.org/asbmb-today/ca… Elizabeth Stivison 🌻 ASBMB

In memoriam | Daniel N. Hebert's (1962–2024) colleagues remember the passionate glycobiologist, scientist, caring mentor and kind friend. ow.ly/WccX50VjC9z

Join us in congratulating Kayunta Johnson-Winters of The University of Texas at Arlington on being named a 2025 ASBMB Fellow! Her research interests are on F420 cofactor dependent enzymes, using steady state and pre–steady state kinetic methods. bit.ly/416Ydhb #ASBMBFellows #ASBMB25

A new study in the Journal of Biological Chemistry reveals #NXP900, a promising kinase inhibitor targeting inactive Src family kinases. Early trials show it's effective against head & neck and esophageal squamous cell carcinomas: asbmb.org/asbmb-today/sc… ASBMB

Colorado College’s RCU Designation highlights our growing research impact. 🔬 Prof. Neena Grover, an expert in RNA stability & science education, will be a keynote speaker at ASBMB’s annual meeting next month. Read more: coloradocollege.edu/newsevents/new… #RCU #Biochemistry #ASBMB2025

Inside Journal of Biological Chemistry: Scientists reported a new kinase inhibitor, NXP900, that targets the inactive form of SFKs. The team showed that head & neck as well as esophageal squamous cell #carcinomas are sensitive to NXP900 treatment in cell culture & animals. ow.ly/uPHX50Vl1P9

A new study in the Journal of Biological Chemistry reveals #NXP900, a promising kinase inhibitor targeting inactive Src family kinases. Early trials show it's effective against head & neck and esophageal squamous cell carcinomas: asbmb.org/asbmb-today/sc… ASBMB

Download a poster from ASBMB that celebrates Women In STEM #WomensHistoryMonth asbmb.org/diversity/wome…

ASBMB has named the 2025 winners of the JBC/Herbert Tabor Early Career Investigator Awards! These awards honor the late Herbert Tabor’s legacy in science and decades-long service to Journal of Biological Chemistry. Please join us in congratulating to this year's winners! ow.ly/WUVa50VnCYP

➡️How cells recover from stress. ➡️Cancer cells need cysteine to proliferate. ➡️Method to make small membrane proteins. Read about papers on these topics recently published in Journal of Biological Chemistry: ow.ly/VHun50Vpqtv. #CellBiology #CancerResearch #Biochemistry #MolecularBiology

“My hope is that during the coming years, the unprecedented assault on scientific truth that has adversely impacted public health in our nation comes to an end so that the citizens of our country can fully benefit from the breadth of advances in medical science.” —Peter Marks,

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss & more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity & immune rejection. ➡️More from Marissa Locke Rottinghaus: ow.ly/YfSN50VsPOa.

Advancing iPS-Based Therapies: A Great Discussion with Marissa Rottinghaus Marissa Locke Rottinghaus on Clinical Breakthroughs and Patient Impact asbmb.org/asbmb-today/sc…

Curious how space cats help me survive Ph.D. candidacy? Find out in my latest essay for ASBMB 🚀🐱